Literature DB >> 34028755

Mouse Models of Skin Fibrosis.

Aleix Rius Rigau1, Markus Luber1, Jörg H W Distler2.   

Abstract

Systemic sclerosis (SSc) is a rare systemic autoimmune disease associated with a high mortality. The first histopathological hallmarks are vasculopathy and inflammation, followed by fibrosis of the skin and internal organs. The molecular and cellular mechanisms are incompletely understood. Rodent models provide important insights into the pathogenesis of SSc and are a mainstay for the development of novel targeted therapies. Here we describe the mechanistic insights of inducible and genetic models, and also discuss in detail the limitations and pitfalls of the most frequently used SSc mouse models. We also describe protocols for running the established bleomycin-induced scleroderma skin fibrosis model.

Entities:  

Keywords:  Bleomycin; Chronic graft-versus-host disease; Mouse model; Skin fibrosis; Systemic sclerosis

Year:  2021        PMID: 34028755     DOI: 10.1007/978-1-0716-1382-5_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  54 in total

Review 1.  Animal models of systemic sclerosis: prospects and limitations.

Authors:  Christian Beyer; Georg Schett; Oliver Distler; Jörg H W Distler
Journal:  Arthritis Rheum       Date:  2010-10

Review 2.  Scleroderma.

Authors:  Armando Gabrielli; Enrico V Avvedimento; Thomas Krieg
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

3.  Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc.

Authors:  Ruifang Liang; Rosebeth Kagwiria; Ariella Zehender; Clara Dees; Christina Bergmann; Andreas Ramming; Dorota Krasowska; Małgorzata Michalska-Jakubus; Alexander Kreuter; Max E Kraner; Georg Schett; Jörg H W Distler
Journal:  Ann Rheum Dis       Date:  2019-06-08       Impact factor: 19.103

4.  Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis.

Authors:  Tatjana Mallano; Katrin Palumbo-Zerr; Pawel Zerr; Andreas Ramming; Barbara Zeller; Christian Beyer; Clara Dees; Jingang Huang; Tsonwin Hai; Oliver Distler; Georg Schett; Jörg H W Distler
Journal:  Ann Rheum Dis       Date:  2015-01-14       Impact factor: 19.103

5.  Studies on bleomycin.

Authors:  H Umezawa; M Ishizuka; K Maeda; T Takeuchi
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

6.  The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.

Authors:  Ruifang Liang; Barbora Šumová; Cinzia Cordazzo; Tatjana Mallano; Yun Zhang; Thomas Wohlfahrt; Clara Dees; Andreas Ramming; Dorota Krasowska; Małgorzata Michalska-Jakubus; Oliver Distler; Georg Schett; Ladislav Šenolt; Jörg H W Distler
Journal:  Ann Rheum Dis       Date:  2016-10-28       Impact factor: 19.103

Review 7.  Pulmonary toxicity of antitumor agents.

Authors:  F M Muggia; A C Louie; B I Sikic
Journal:  Cancer Treat Rev       Date:  1983-12       Impact factor: 12.111

Review 8.  Fos/AP-1 proteins in bone and the immune system.

Authors:  Erwin F Wagner; Robert Eferl
Journal:  Immunol Rev       Date:  2005-12       Impact factor: 12.988

Review 9.  Shared and distinct mechanisms of fibrosis.

Authors:  Jörg H W Distler; Andrea-Hermina Györfi; Meera Ramanujam; Michael L Whitfield; Melanie Königshoff; Robert Lafyatis
Journal:  Nat Rev Rheumatol       Date:  2019-11-11       Impact factor: 20.543

10.  PU.1 controls fibroblast polarization and tissue fibrosis.

Authors:  Thomas Wohlfahrt; Simon Rauber; Steffen Uebe; Markus Luber; Alina Soare; Arif Ekici; Stefanie Weber; Alexandru-Emil Matei; Chih-Wei Chen; Christiane Maier; Emmanuel Karouzakis; Hans P Kiener; Elena Pachera; Clara Dees; Christian Beyer; Christoph Daniel; Kolja Gelse; Andreas E Kremer; Elisabeth Naschberger; Michael Stürzl; Falk Butter; Michael Sticherling; Susetta Finotto; Alexander Kreuter; Mark H Kaplan; Astrid Jüngel; Steffen Gay; Stephen L Nutt; David W Boykin; Gregory M K Poon; Oliver Distler; Georg Schett; Jörg H W Distler; Andreas Ramming
Journal:  Nature       Date:  2019-01-30       Impact factor: 49.962

View more
  1 in total

1.  Scleroderma-like Impairment in the Network of Telocytes/CD34+ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis.

Authors:  Irene Rosa; Eloisa Romano; Bianca Saveria Fioretto; Daniele Guasti; Lidia Ibba-Manneschi; Marco Matucci-Cerinic; Mirko Manetti
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.